The use of U‐500 regular insulin in the management of patients with obesity and insulin resistance
- 4 April 2013
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 15 (10) , 882-887
Abstract
The rise in prevalence of obesity and diabetes has created a challenge in managing increasing numbers of patients who require high doses of insulin. This article reviews the published literature on the properties of U‐500 insulin and its use in clinical practice. U‐500 insulin is likely to have a longer time to peak effect and a longer duration of action than similar doses of U‐100 insulin. Evidence for its use in clinical practice rests on retrospective case series, which suggests that the use of U‐500 insulin either by multiple daily injections or a continuous subcutaneous insulin infusion is effective in improving glycaemic control. To prevent insulin dosing and administration errors, great care must be taken in providing staff and patient education, and in developing policies for the management of patients on U‐500 insulin who are admitted to hospital.Keywords
This publication has 36 references indexed in Scilit:
- Changes to medication-use processes after overdose of U-500 regular insulinAmerican Journal of Health-System Pharmacy, 2012
- Durability of glycemic control using U-500 insulinDiabetes Research and Clinical Practice, 2012
- Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese SubjectsDiabetes Care, 2011
- Use of concentrated insulin human regular (U-500) for patients with diabetesAmerican Journal of Health-System Pharmacy, 2010
- U-500 Regular InsulinDiabetes Care, 2009
- Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus2009
- U-500 Insulin: When More With Less Yields SuccessDiabetes Spectrum, 2009
- U‐500 insulin: why, when and how to use in clinical practiceDiabetes/Metabolism Research and Reviews, 2006
- Practical aspects in the usage of U‐500 insulinPractical Diabetes International, 2006
- Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin MixturesDiabetes Care, 1981